Michael Benkowitz sold $3.7M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $371.05, traded Feb 18, 2025, filed Feb 19, 2025.
Score components
- +20RolePresident
- +25Trade size$3.7M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562180-25-001348, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | MOption exercise Common Stockindirect: by Trust10b5-1 | +7,500 | $111.00 | $833k | 7,500 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -100 | $366.19 | $37k | 7,400 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -600 | $368.32 | $221k | 6,800 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,432 | $369.65 | $529k | 5,368 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,068 | $370.70 | $396k | 4,300 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -2,351 | $371.47 | $873k | 1,949 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,549 | $372.63 | $577k | 400 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -400 | $373.67 | $149k | 0 | Feb 19, 2025 |
| Feb 18, 2025 | MOption exercise Common Stockindirect: by Trust10b5-1 | +2,500 | $111.00 | $278k | 2,500 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -200 | $367.97 | $74k | 2,300 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -500 | $369.43 | $185k | 1,800 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -601 | $370.85 | $223k | 1,199 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -600 | $371.67 | $223k | 599 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -499 | $372.82 | $186k | 100 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -100 | $374.18 | $37k | 0 | Feb 19, 2025 |
| Feb 18, 2025 | MOption exercise Stock Optionderivativeindirect: by Trust10b5-1 | -7,500 | $0.00 | $0 | 14,679 | Feb 19, 2025 |
| Feb 18, 2025 | MOption exercise Stock Optionsderivativeindirect: by Trust10b5-1 | -2,500 | $0.00 | $0 | 7,000 | Feb 19, 2025 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $3.9M 7,580 shares | -2% | |
| 38Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $1.1M 1,920 shares | -1% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.